Publications 

Journal Articles


Destabilized 3’UTR elements therapeutically degrade ERBB2 mRNA in drug resistant ERBB2+ cancer models 

Awah CU, Glemaud Y, Levine F, Yang K, Ansary A, Dong F, Ash L, Zhao J, Ogunwobi OO. Front. Genet. 2023, 14:1184600. doi: 10.3389/fgene.2023.1184600.

Effective Recruitment Strategies Utilized to Examine Dietary Practices of Blacks in New York City in the Midst of the COVID-19 Pandemic
Johnson CK, Leung MM, Ma GX, Ogunwobi OO. Journal of Racial and Ethnic Health Disparities. 2023, in press. DOI: 10.1007/s40615-023-01559-9.

A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus
Ma GX, Zhu L, Tan Y, Zhai S, Ma X, Ogunwobi OO, Yang WJ, Ting T, Kim S, Wang MQ. Digestive Diseases and Sciences. 2023. DOI: 10.1007/s10620-023-07840-5. 

Racism Doesn’t Cause Prostate Cancer, It Causes Prostate Cancer Death
Vickers A, Mahal B, Ogunwobi OO. Journal of Clinical Oncology. 2023. DOI: 10.1200/JCO.22.02203.

Dietary Behavior and Urinary Gallic Acid Concentration Differences Among Underserved Elder Racial and Ethnic Minorities in New York City
Zambrano CN, Lu W, Johnson C, Beeber M, Panitz A, Ibrahim S, Fraser M, Ma GX, Navder K, Yeh M, Ogunwobi OO. Cancer Causes & Control. 2022, 33(7):929-937. DOI: 10.1007/s10552-022-01581-y.

Genome Scale CRISPR Cas9a Knockout Screen Reveals Genes That Control Glioblastoma Susceptibility to the Alkylating Agent Temozolomide
Awah C, Winter J, Ogunwobi OO. All Life. 2022, 15(1): 88–93. DOI: 10.1080/26895293.2021.2024895.

Increased Risk of COVID-19 Related Admissions in Active Solid Organ Cancer Patients in the West Midlands Region of the United Kingdom: A Retrospective Cohort Study
Akingboye A, Mahmood F, Amiruddin N, Reay M, Nightingale P, Ogunwobi OO. BMJ Open. 2021, 11: e053352, DOI: 10.1136/bmjopen-2021-053352.

NSUN6, an RNA Methyltransferase of 5-mC Controls Glioblastoma Response to Temozolomide (TMZ) via NELFB and RPS6KB2 Interaction
Awah C, Winter J, Mazdoom C, Ogunwobi OO. Cancer Biology & Therapy. 2021, 27:1-11. DOI: 10.1080/15384047.2021.1990631.

MicroRNA-1205 Regulation of FRYL in Prostate Cancer
Naidoo M, Levine F, Gillot T, Orunmuyi AT, Olapade-Olaopa EO, Ali T, Krampis K, Pan C, Dorsaint P, Sboner A and Ogunwobi OO. Frontiers in Cell and Developmental Biology. 2021, 9:647485. DOI: 10.3389/fcell.2021.647485.

Prostac: A New Composite Score With Potential Predictive Value in Prostate Cancer
Asante-Asamani E, Pal G, Liu L, Ogunwobi OO. Frontiers in Oncology. 2021, 11:644665. DOI: 10.3389/fonc.2021.644665.

Targeting PVT1 Exon 9 Re-Expresses Claudin 4 Protein and Inhibits Migration by Claudin—Low Triple Negative Breast Cancer Cells
Levine F, Ogunwobi OO. Cancers. 2021, 13(5), 1046. DOI: 10.3390/cancers13051046.

Leptin Activates Akt in Oesophageal Cancer Cells via Multiple Atorvastatin-Sensitive Small GTPases
Beales ILP, Ogunwobi OO. Molecular and Cellular Biochemistry. 2021. DOI: 10.1007/s11010-021-04067-8.

Editorial: PVT1 in Cancer
Ogunwobi OO, Segura MF. Frontiers in Oncology. 2020, 10: 588786. DOI: 10.3389/fonc.2020.588786.

Biomarkers in Colorectal Cancer: Current Research and Future Prospects
Ogunwobi OO, Mahmood F, Akingboye A. International Journal of Molecular Sciences. 2020, 21(15), 5311. DOI: 10.3390/ijms21155311.
* Selected as one of the Highly Cited Papers of the International Journal of Molecular Sciences published in 2020.

Circulating Tumor Cell Migration Requires Fibronectin Acting through Integrin B1 or SLUG
Huaman J, Ogunwobi OO. Cells. 2020, 9(7), 1594. DOI: 10.3390/cells9071594.

Population Differentiation at the PVT1 Gene Locus: Implications for Prostate Cancer
Pal G, Di L, Orunmuyi A, Olapade-Olaopa EO, Qiu W, Ogunwobi OO. G3: Genes, Genomes, Genetics. 2020, 10 (7): 2257-2264. DOI: 10.1534/g3.120.401291.

Oncogenic Role of PVT1 and Therapeutic Implications
Onagoruwa OT, Pal G, Ochu C, Ogunwobi OO. Frontiers in Oncology. 2020, 10:17. DOI: 10.3389/fonc.2020.00017.

Primary Diffuse Large B-Cell Lymphoma of the Breast: A Rare Case Report and Review of the Literature
Alegbeleye BJ, Ogunwobi OO. International Journal of Scientific Advances. 2020, 1 (2): 79-86. DOI: 10.51542/ijscia.v1i2.1.

Online Versus In-Person Training of Community Health Workers to Enhance Hepatitis B Virus Screening Among Korean Americans: Evaluating Cost & Outcomes
Shireman TI, Adia AC, Tan Y, Zhu L, Rhee J, Ogunwobi OO, Ma GX. Preventive Medicine Reports. 2020. DOI: 10.1016/j.pmedr.2020.101131.

Copy Number-Based Quantification Assay for Non-Invasive Detection of PVT1-Derived Transcripts
Pal G, Ogunwobi OO. PLoS ONE. 2019, 14(12): e0226620. DOI: 10.1371/journal.pone.0226620.

Long Noncoding RNA from PVT1 Exon 9 Is Overexpressed in Prostate Cancer and Induces Malignant Transformation and Castration Resistance in Prostate Epithelial Cells
Pal G, Huaman J, Levine F, Orunmuyi AT, Olapade-Olaopa EO, Onagoruwa OT, Ogunwobi OO. Genes. 2019, 10(12), 964. DOI: 10.3390/genes10120964.

Oxytocin and Oxytocin Receptor Alterations Decreased Survival and Increased Chemoresistance in Patients With Pancreatic Cancer
Harricharran T, Ogunwobi OO. Hepatobiliary & Pancreatic Diseases International. 2020. DOI: 10.1016/j.hbpd.2019.12.002.

Selective Inhibition of Liver Cancer Cells Using Venom Peptide
Anand P, Filipenko P, Huaman J, Lyudmer M, Hossain M, Santamaria C, Huang K, Ogunwobi OO, Holford M. Marine Drugs. 2019, 17(10), 587. DOI: 10.3390/md17100587.
* Featured in PBS/NOVA’s “Beyond the Elements: Reactions

Dietary Behavior and Urinary Gallic Acid Concentrations in Older Minority Residents of East Harlem, New York City
Zambrano C, Johnson C, Lu W, Beeber M, Panitz A, Wyka K, Ibrahim S, Fraser M, Bhimla A, Tan Y, Navder K, Yeh M, Ma GX, Ogunwobi OO. Journal of Racial and Ethnic Health Disparities. 2020, 7, 217–223. DOI: 10.1007/s40615-019-00649-x.

EZH2 Downregulation Augments the Effect of Irradiation in Reducing Pancreatic Cancer Cell Proliferation In Vitro
Agrawal R, Chen M, Ogunwobi OO, Bukhari Z, Haseeb MA, Martello LA. Annals of Clinical & Laboratory Science. 2020, 50(1):45–56.

Emergence of Neural Regulatory Mechanisms in Carcinogenesis
Harricharran T, Ogunwobi OO. World Journal of Clinical Oncology. 2019, 10(8): 279-282. DOI: 10.5306/wjco.v10.i8.279.

Chemoresistance Mediated by ceRNA Networks Associated with the PVT1 Locus
Ogunwobi OO, Kumar A. Frontiers in Oncology. 2019, 9: 834. DOI: 10.3389/fonc.2019.00834.

Oxytocin Receptor Genetic Alterations in Hepatocellular Carcinoma
Harricharran T, Ogunwobi OO. Springer Nature Comprehensive Clinical Medicine. 2019, 1(7), 523-526. DOI: 10.1007/s42399-019-00085-2.

Fibronectin Regulation of Integrin B1 and SLUG in Circulating Tumor Cells
Huaman J, Naidoo M, Zang X, Ogunwobi OO. Cells. 2019, 8, 618. DOI: 10.3390/cells8060618.

PVT1 Signaling Is a Mediator of Cancer Progression
Derderian C, Orunmuyi AT, Olapade-Olaopa EO, Ogunwobi OO. Frontiers in Oncology. 2019, 9: 502. DOI: 10.3389/fonc.2019.00502.

Evaluation of a Transdisciplinary Cancer Research Training Program for Under-Represented Minority Students
Halpern MT, Dodd SJ, Fang CY, Tan Y, Zhu L, Ogunwobi OO, Ma GX. Informing Science Institute. 2019: 99-108. DOI: 10.28945/4343.

SPEECH: Synergistic Partnership for Enhancing Equity in Cancer Health
Ogunwobi OO, Ma GX. Cancer Health Disparities. 2019, 4: e1.e5.

Hepatitis B Virus Screening and Vaccination in First-Generation African Immigrants: A Pilot Study
Ogunwobi OO, Dibba O, Zhu L, Ilboudo A, Tan Y, Fraser MA, Ma GX. Journal of Community Health. 2019, 44 (6) 1037-1043. DOI: 10.1007/s10900-019-00668-z.

Mechanisms of Hepatocellular Carcinoma Progression
Ogunwobi OO, Harricharran T, Huaman J, Galuza A, Odumuwagun O, Tan Y, Ma GX, Nguyen MT. World Journal of Gastroenterology. 2019, 25(19): 2279-2293. DOI: 10.3748/wjg.v25.i19.2279.

Context Dependent Roles of MDMX (MDM4) and MDM2 in Breast Cancer Proliferation and Circulating Tumor Cells
Gao C, Xiao G, Piersigilli A, Gou J, Ogunwobi O, Bargonetti J. Breast Cancer Research. 2019, 21(1): 5. DOI: 10.1186/s13058-018-1094-8.

Oxytocin and Cancer: An Emerging Link
Lerman B, Harricharran T, Ogunwobi OO. World Journal of Clinical Oncology. 2018; 9(5): 74-82. DOI: 10.5306/wjco.v9.i5.74.

Psychosocial Predictors of HBV Screening Behavior among Vietnamese Americans
Lee M, Zhu L, Wang MQ, Wei Z, Tan Y, Nguyen MT, Ogunwobi OO, Ma GX. American Journal of Health Behavior. 2017, Sep 1;41(5):561-570. DOI: 10.5993/AJHB.41.5.5.

miRNAs Associated With Prostate Cancer Risk and Progression
Luu HN, Lin H, Sørensen K, Ogunwobi OO, Kumar N, Chornokur G, Phelan CM, Jones D, Kidd L, Batra J, Yamoah K, Berglund A, Rounbehler RJ, Yang M, Lee SH, Kang N, Kim SJ, Park J, Di Pietro G. BMC Urology. 2017, 17(1):18. DOI: 10.1186/s12894-017-0206-6.

A Novel microRNA-1207-3p/FNDC1/FN1/AR Regulatory Pathway in Prostate Cancer
Das DK, Ogunwobi OO. RNA & Disease. 2017; 4: e1503. DOI: 10.14800/rd.1503.

Fibronectin and Androgen Receptor Expression Data in Prostate Cancer Obtained From a RNA-Sequencing Bioinformatics Analysis
Das DK, Ali T, Krampis K, Ogunwobi OO. Data in Brief. 2017, 11:131-135. DOI: 10.1016/j.dib.2017.01.016.

miR-1207-3p Regulates the Androgen Receptor in Prostate Cancer via FNDC1/Fibronectin
Das DK, Naidoo M, Ilboudo A, Park JY, Ali T, Krampis K, Robinson BD, Osborne JR, Ogunwobi OO. Experimental Cell Research. 2016, 348(2):190-200. DOI: 10.1016/j.yexcr.2016.09.021.

Racial/Ethnic Disparities in Genomic Sequencing
Spratt DE, Chan T, Waldron L, Speers C, Feng FY, Ogunwobi OO, Osborne JR. JAMA Oncology. 2016, 2(8):1070-4. DOI: 10.1001/jamaoncol.2016.1854.

miR-1207-3p Is a Novel Prognostic Biomarker of Prostate Cancer
Das DK, Osborne JR, Park JY, Ogunwobi OO. Translational Oncology. 2016, 9(3): 236–241. DOI: 10.1016/j.tranon.2016.04.005.

PVT1 Exon 9: A Potential Biomarker of Aggressive Prostate Cancer?
Ilboudo A, Chouhan J, McNeil BK, Osborne JR, Ogunwobi OO. International Journal of Environmental Research and Public Health. 2016, 13(1), 12. DOI:10.3390/ijerph13010012. 

A “Patient-Like” Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Das DK, Durojaiye V, Ilboudo A, Naidoo MK, Ogunwobi OO. Journal of Visualized Experiments. 2015, (104), e52858. DOI:10.3791/52858.

Isolation and Propagation of Circulating Tumor Cells From a Mouse Cancer Model
Das DK, Naidoo MK, Ilboudo A, DuBois P, Durojaiye V, Liu C, Ogunwobi OO. Journal of Visualized Experiments. 2015, (104), e52861. DOI: 10.3791/52861.

“Tissue Is the Issue”: Circulating Tumor Cells in Pancreatic Cancer
George TJ, Ogunwobi OO, Sheng W, Fan ZH, Liu C. Journal of Gastrointestinal Cancer. 2014, 45:222-225. DOI: 10.1007/s12029-014-9638-3.

Capture, Release and Culture of Circulating Tumor Cells From Pancreatic Cancer Patients Using an Enhanced Mixing Chip
Sheng W, Ogunwobi OO, Chen T, Zhang J, George TJ, Liu C, Fan ZH. Lab on a Chip. 2014, 14(1):89-98. DOI: 10.1039/c3lc51017d.

Adiponectin Inhibits Leptin-Induced Oncogenic Signalling in Oesophageal Cancer Cells by Activation of PTP1B
Beales IL, Garcia-Morales C, Ogunwobi OO, Mutungi G. Molecular and Cellular Endocrinology. 2014, 382 (1): 150-158. DOI: 10.1016/j.mce.2013.08.013.

Epigenetic Upregulation of c-Met and HGF Drives Metastasis in Hepatocellular Carcinoma
Ogunwobi OO, Puszyk W, Dong H, Liu C. PLoS One. 2013, 8(5): e63765. DOI: 10.1371/journal.pone.0063765.

OPA1 Down-Regulation Is Involved in Sorafenib-Induced Apoptosis in Hepatocellular Carcinoma
Zhao X, Tian C, Puszyk W, Ogunwobi OO, Cao M, Wang T, Cabrera R, Nelson D, Liu C. Laboratory Investigation. 2013, 93(1):8-19. DOI: 10.1038/labinvest.2012.144.

Therapeutic and Prognostic Importance of Epithelial-Mesenchymal Transition in Liver Cancers: Insights From Experimental Models
Ogunwobi OO, Liu C. Critical Reviews in Oncology/Hematology. 2012, 83(3):319-28. DOI: 10.1016/j.critrevonc.2011.11.007.

COX-2 and Akt Mediate Multiple Growth Factor-Induced Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma
Ogunwobi OO, Wang T, Zhang L, Liu C. Journal of Gastroenterology and Hepatology, 2012, 27 (3): 566-578 (Editorial on pages 418-420). DOI: 10.1111/j.1440-1746.2011.06980.x.

Hepatocyte Growth Factor Upregulation Promotes Carcinogenesis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma via Akt and COX-2 Pathways
Ogunwobi OO, Liu C. Clinical & Experimental Metastasis. 2011, 28 (8): 721-31. DOI: 10.1007/s10585-011-9404-x.

Survivin Inhibition Is Critical for Bcl-2 Inhibitor-Induced Apoptosis in Hepatocellular Carcinoma Cells
Zhao X, Ogunwobi OO, Liu C. PLoS One. 2011, 6 (8): e21980. DOI: 10.1371/journal.pone.0021980.

Intrahepatic Cholangiocarcinoma Progression: Prognostic Factors and Basic Mechanisms
Sirica AE, Dumur CI, Campbell DJ, Almenara JA, Ogunwobi OO, Dewitt JL. Clinical Gastroenterology and Hepatology. 2009, 7 (11 Suppl): S68-78. DOI: 10.1016/j.cgh.2009.08.023.

Microsomal Prostaglandin E Synthase-1 Inhibition Blocks Proliferation and Enhances Apoptosis in Esophageal Adenocarcinoma Cells Without Affecting Endothelial Prostacyclin Production
Beales ILP, Ogunwobi OO. International Journal of Cancer. 2010, 126 (9) 2247-55. DOI: 10.1002/ijc.24875.

Glycine-Extended Gastrin Inhibits Apoptosis in Barrett’s Oesophageal and Oesophageal Adenocarcinoma Cells Through JAK2/STAT3 Activation
Beales I, Ogunwobi O. Journal of Molecular Endocrinology. 2009, 42 (4): 305-18. DOI: 10.1677/JME-08-0096.

Statins Inhibit Proliferation and Induce Apoptosis In Barrett’s Oesophageal Adenocarcinoma Cells
Ogunwobi OO, Beales ILP. American Journal of Gastroenterology. 2008, 103 (4): 825-837 (Editorial on pages 838-41). DOI: 10.1111/j.1572-0241.2007.01773.x.

Glycine-Extended Gastrin Stimulates Proliferation via JAK2- and Akt-Dependent NF-ΚB Activation in Barrett’s Oesophageal Adenocarcinoma Cells
Ogunwobi OO, Beales ILP. Molecular and Cellular Endocrinology. 2008, 296 (1-2): 94-102. DOI: 10.1016/j.mce.2008.08.004.

Leptin Stimulates Proliferation of Oesophageal Adenocarcinoma Cells via Upregulation of Epidermal Growth Factor Receptor Ligands
Ogunwobi OO, Beales ILP. British Journal of Biomedical Science. 2008, 65 (3): 121-7. DOI: 10.1080/09674845.2008.11732814.

Globular Adiponectin, Acting via Adiponectin Receptor-1, Inhibits Leptin-Stimulated Oesophageal Adenocarcinoma Cell Proliferation
Ogunwobi OO, Beales ILP. Molecular and Cellular Endocrinology. 2008, 285 (1-2): 43-50. DOI: 10.1016/j.mce.2008.01.023.

Leptin Stimulates Proliferation and Inhibits Apoptosis in Barrett’s Oesophageal Adenocarcinoma Cells by COX-2 Dependent, PGE2 Mediated Transactivation of the EGF Receptor and JNK Activation
Ogunwobi O, Mutungi G, Beales ILP. Endocrinology. 2006, 147(9): 4505-4516. DOI: 10.1210/en.2006-0224.

The Anti-Apoptotic and Growth Stimulatory Actions of Leptin in Human Colon Cancer Cells Involves Activation of JNK Mitogen Activated Protein Kinase, JAK2 and PI3-kinase/Akt
Ogunwobi OO, Beales ILP. International Journal of Colorectal Disease. 2007, 22 (4): 401-409. DOI: 10.1007/s00384-006-0181-y.

Cyclo-Oxygenase-Independent Inhibition of Apoptosis and Stimulation of Proliferation by Leptin in Human Colon Cancer Cells
Ogunwobi OO, Beales ILP. Digestive Diseases and Sciences. 2007 52 (8): 1934-1945. DOI: 10.1007/s10620-007-9784-6.

Leptin Synergistically Enhances the Anti-Apoptotic and Growth-Promoting Effects of Acid in OE33 Oesophageal Adenocarcinoma Cells in Culture
Ogunwobi OO, Beales ILP. Molecular and Cellular Endocrinology. 2007, 274 (1-2): 60-68. DOI: 10.1016/j.mce.2007.05.017.

Activation of Akt Is Increased in the Dysplasia-Carcinoma Sequence in Barrett’s Oesophagus and Contributes to Increased Proliferation and Inhibition of Apoptosis: A Functional and Immunohistochemical Study
Beales ILP, Ogunwobi OO, Cameron E, El-Amin K, Mutungi G and Wilkinson M. BMC Cancer. 2007, 7: 97. DOI: 10.1186/1471-2407-7-97.

The Role of Adiponectin in Colitis
Ogunwobi OO, Beales ILP. Gastroenterology. 2007, 132 (3): 1199-1200. DOI: 10.1053/j.gastro.2007.02.014.

Glycine-Extended Gastrin Inhibits Apoptosis in Colon Cancer Cells via Separate Activation of Akt and JNK Pathways
Beales ILP, Ogunwobi O. Molecular and Cellular Endocrinology. 2006, 247 (1-2): 140-149. DOI: 10.1016/j.mce.2005.12.050.

Adiponectin Stimulates Proliferation and Cytokine Secretion in Colonic Epithelial Cells
Ogunwobi OO, Beales ILP. Regulatory Peptides. 2006 134 (2-3): 105-113. DOI: 10.1016/j.regpep.2006.02.001.

Glycine-Extended Gastrin Stimulates Proliferation and Inhibits Apoptosis in Colon Cancer Cells via Cyclo-Oxygenase Independent Pathways
Ogunwobi OO, Beales ILP. Regulatory Peptides. 2006, 134 (1): 1-8. DOI: 10.1016/j.regpep.2005.08.002

Adipokines and Gastrointestinal Disease
Beales ILP, Ogunwobi O. Alimentary Pharmacology & Therapeutics. 2006, 24: 1127. DOI: 10.1111/j.1365-2036.2006.03030.x

 

Peer-Reviewed Book Chapters


Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma
Huaman J, Bach C, Ilboudo A, Ogunwobi OO. Precision Molecular Pathology of Liver Cancer, Edited by Chen Liu, September 2017, Springer.

Leptin, Cell Cycle and Cancer
Ogunwobi OO. Leptin - Regulation and Clinical Applications, Edited by Sam Dagogo-Jack, December 2014, Springer. 

 

Articles Undergoing Peer-Review


Destabilized 3’UTR ARE Therapeutically Degrades ERBB2 in Drug-Resistant ERBB2+ Cancer Models
Chidiebere U Awah, Yana Glemaud, Fayola Levine, Kiseok Yang, Afrin Ansary, Fu Dong, Leonard Ash, Junfei Zhang, Daniel Weiser, Olorunseun O Ogunwobi. 2022; bioRxiv 2022.08.14.503914. DOI: 10.1101/2022.08.14.503914.

Intracellular Interaction of FNDC1/FN1/AR/cMYC in Prostate Cancer Cells
Priyanka Ghosh, Olorunseun O Ogunwobi. 2023; bioRxiv 2023.02.23.529660v1. DOI: 10.1101/2023.02.23.529660.

Stem Cell Therapy of Solid Organ Cancers
Ogunwobi OO, Boylu B, Ochu C. Comprehensive Hematology and Stem Cell Research, Edited by Nima Rezaei, Elsevier.